Maps for Disease

A collaboration between Doctors Without Borders, the Red Cross, and other organizations aims to map developing cities across the globe to improve disease response efforts.

Written byJef Akst
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, SUE CLARKIn 2010, Ivan Gayton of Doctors Without Borders responded to call from a nun in Haiti, who described how her town was suffering from an outbreak of cholera following a massive earthquake. But finding her wasn’t easy, Gayton recounted to The Guardian, in large part because there was no decent map of the area. “Much of the time [the address given] may as well be random syllables,” Gayton said. “If there was a point source for cholera in Haiti, we wouldn’t have known where it was. We needed a map—to be able to correlate the alerts we hear and our patient origins to something on the ground.”

Enter the Missing Maps project, a collaborative effort launched this month by the Humanitarian OpenStreetMap Team (HOT), Doctors Without Borders, the American Red Cross, and the British Red Cross that aims to create free digital maps for every village and town on the planet. The Guardian called it “nothing less than a human genome project for the world’s cities.”

The method for developing the new maps was created by the HOT, and involves volunteers around the world. Anyone with an internet connection can use a simple point-and-click tool to note the locations of landmarks, such as roads, parks, and buildings on satellite images that have been entered into free mapping software called OpenStreetMap. The satellite images are then removed and the rudimentary maps printed, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies